What does Evogene Ltd. do?

Evogene Ltd. (EVGN.TA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is EVGN.TA's market cap?

Evogene Ltd. (EVGN.TA) has a market capitalization of approximately $1.40 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does EVGN.TA pay a dividend?

No — Evogene Ltd. (EVGN.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is EVGN.TA profitable?

Evogene Ltd. (EVGN.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

EVGN.TA

Evogene Ltd.

TLV·Biotechnology · Healthcare

ILA 163.00ILA 5.90−3.49%

Market capILA 1.40B·Aug 26 2:24 PM UTC

Price Chart

ILA 163.00−ILA 5.90 (−3.49%)today

−98.19%CAGR −55.20%

Select date range

FromTo

Jun 13, 2007Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

EVGN.TA does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateNov 18

Last Report DateAug 18

Reported vs Estimate−ILA 0.42 vs −ILA 0.80

Earnings Surprise+48.1%

FinancialsFinancials Tab

Revenue$1.31M

Net Income−$9.10M

Net Margin−696.3%

Operating Cash Flow−$11.86M

Capital Expenditures$30.81K

Free Cash Flow−$11.89M

Return on Equity—

Return on Invested Capital−22.1%

Net Cash$7.19M

Analyst Estimates

PRO

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.

Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for EVGN.TA and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how EVGN.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for EVGN.TA and 80,000+ other tickers.

About Evogene Ltd.

Evogene Ltd. is a computational biology firm specializing in the identification and advancement of products across human health and agricultural sectors. Its proprietary Computational Predictive Biology (CPB) platform leverages deep biological insights, big data, and artificial intelligence to precisely uncover and guide the creation of life science solutions, including novel microbes, small molecules, and genetic components. The company operates through distinct divisions: Agriculture, Human Health, and Industrial Applications. The Agriculture division concentrates on improving crop…

CEO: Ofer Haviv
Sector: Healthcare
Industry: Biotechnology
Exchange: TLV
Employees: 52
Website: www.evogene.com

Peers

Peers Tab

XTLB.TA

XTL Biopharmaceuticals Ltd.

Can-Fite BioPharma Ltd.

Cap

ILA 2.2B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About EVGN.TA

What does Evogene Ltd. do?: Evogene Ltd. (EVGN.TA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is EVGN.TA's market cap?: Evogene Ltd. (EVGN.TA) has a market capitalization of approximately $1.40 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does EVGN.TA pay a dividend?: No — Evogene Ltd. (EVGN.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is EVGN.TA profitable?: Evogene Ltd. (EVGN.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.